IART Logo

Integra LifeSciences Holdings Corporation (IART) 

NASDAQ
Market Cap
$2.08B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
76 of 776
Rank in Industry
6 of 100

Largest Insider Buys in Sector

IART Stock Price History Chart

IART Stock Performance

About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and …

Insider Activity of Integra LifeSciences Holdings Corporation

Over the last 12 months, insiders at Integra LifeSciences Holdings Corporation have bought $2.5M and sold $331,193 worth of Integra LifeSciences Holdings Corporation stock.

On average, over the past 5 years, insiders at Integra LifeSciences Holdings Corporation have bought $1.45M and sold $63.15M worth of stock each year.

Highest buying activity among insiders over the last 12 months: ESSIG STUART (Exec. Chairman of the Board) — $3M. HILL BARBARA B (director) — $995,816.

The last purchase of 52,641 shares for transaction amount of $1.5M was made by ESSIG STUART (Exec. Chairman of the Board) on 2024‑05‑23.

List of Insider Buy and Sell Transactions, Integra LifeSciences Holdings Corporation

2024-08-19SaleSVP, Fin & Princ Acct Officer
1,191
0.0015%
$21.58$25,701-10.81%
2024-05-23PurchaseExec. Chairman of the Board
52,641
0.0668%
$28.49$1.5M-26.31%
2024-05-21Purchasedirector
36,350
0.0462%
$27.40$995,816-23.18%
2024-03-06SaleEVP & President, TT
8,348
0.0109%
$36.59$305,492-21.52%
2023-08-09SaleSVP, Fin & PAO
1,177
0.0014%
$44.46$52,329-14.14%
2023-06-01PurchaseEVP, Chief Legal Officer & Sec
2,640
0.0032%
$37.89$100,035+2.88%
2023-06-01PurchasePresident & CEO
7,792
0.0095%
$38.50$299,986+2.88%
2023-03-07SaleEVP & President, CSS
1,843
0.0023%
$54.29$100,064-22.92%
2023-03-01SaleEVP & President, TT
1,566
0.0019%
$55.21$86,463-23.04%
2023-02-27SaleEVP & CHRO
3,767
0.0046%
$57.00$214,731-25.99%
2022-12-08SaleSVP, Fin & Princ Acct Officer
279
0.0003%
$56.22$15,684-21.21%
2022-08-10SaleExecutive Vice President &CHRO
1,165
0.0014%
$55.81$65,020-6.92%
2022-08-05Sale
8,000
0.0096%
$55.78$446,266-5.72%
2022-08-02SaleSVP, Fin & Princ Acct Officer
437
0.0005%
$56.77$24,811-5.27%
2022-06-15SaleExecutive Vice President &CHRO
900
0.0011%
$55.93$50,337-3.92%
2022-05-24SaleExecutive Vice President &CHRO
250
0.0003%
$59.85$14,963-8.85%
2022-04-04SaleExecutive Vice President & COO
6,268
0.0077%
$66.04$413,939-14.16%
2022-03-23Sale10 percent owner
150,000
0.1845%
$64.67$9.7M-11.66%
2022-02-28SaleExecutive Vice President &CHRO
1,254
0.0015%
$67.03$84,056-16.22%
2022-02-09Sale10 percent owner
75,000
0.0891%
$65.82$4.94M-15.02%

Insider Historical Profitability

8.57%
ESSIG STUARTExec. Chairman of the Board
487922
0.6289%
$26.79174
HILL BARBARA Bdirector
36350
0.0469%
$26.7940+10.78%
CARUSO RICHARD E10 percent owner
10291205
13.2649%
$26.79112+23.04%
Schwartz EricEVP, Chief Legal Officer & Sec
48597
0.0626%
$26.7913+2.88%
MOREL DONALD E JRdirector
37112
0.0478%
$26.7920+6.47%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$247.47M8.866.98M-0.46%-$1.14M0.01
BlackRock$235.66M8.446.65M+0.09%+$209,615.850.01
Capital Research Global Investors$209.83M7.515.92M+37.74%+$57.49M0.05
Morgan Stanley$174.22M6.244.91M-6.76%-$12.63M0.01
Wellington Management Company$118.35M4.243.34M+4.81%+$5.43M0.02
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.